Related references
Note: Only part of the references are listed.
Article
Medicine, General & Internal
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
Merryn Voysey et al.
Summary: The ChAdOx1 nCoV-19 vaccine has been shown to have an acceptable safety profile and effectiveness against symptomatic COVID-19, with higher efficacy observed in the group that received a low dose followed by a standard dose.
LANCET (2021)
Review
Hematology
Coagulopathy in COVID-19
Toshiaki Iba et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Article
Medicine, General & Internal
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Fernando P. Polack et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Share Paper
